i2O Therapeutics snags $4m seed

Allston, Massachusetts-based i2O Therapeutics, a developer of a platform for oral delivery of traditionally injectable biological drugs, has raised $4 million in seed funding.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this